The Food and Drugs Authority (FDA) has launched a new online advertisement application portal to improve its operations. This portal aims to simplify the submission, review, and approval process for advertisements of FDA-regulated products, enhancing service delivery across the board.
FDA CEO, Dr. Delese Darko, said the new platform will provide convenience, transparency, and accessibility, enabling customers to submit advertisements, make payments, and receive approvals online, eliminating the need for physical visits.
The introduction of this portal demonstrates the FDA’s commitment to innovation, efficiency, and customer-centricity. It also marks a significant improvement in the way the FDA interacts with and serves its stakeholders.
Under the Public Health Act, 2012 (Act 851), the FDA is responsible for regulating product advertisements. The new portal is expected to simplify this process, providing clear, traceable records of all transactions and communications.
The FDA has encouraged stakeholders to embrace the platform as part of the collective effort to maintain high product quality and safety standards in Ghana. This is one of many initiatives aimed at creating a safe, transparent, and efficient regulatory environment in the country.
